Long-term immunogenicity of hepatitis B vaccination in children and adolescents in a southern Italian town

Infection

Volumn 40, Issue 3, 2012, Pages 299-302

  Stroffolini, T ^a   Guadagnino, V ^b   Caroleo, B ^b   De Sarro, G ^b   Foca A ^b   Liberto, M C ^b   Giancotti, A ^b   Barreca, G S ^b   Marascio, N ^b   Lombardo, F L ^c   Staltari, O ^b  

^a POLICLINICO UMBERTO I   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Anti hepatitis B surface antibodies; Hepatitis B; Long term immunogenicity; Vaccination

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CHILD; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOGENICITY; ITALY; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; SCHOOL CHILD; VACCINATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; ITALY; MALE; TIME FACTORS; YOUNG ADULT;

EID: 84864280927     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0233-2     Document Type: Article

References (14)

1. Stroffolini T, Cialdea L, Tosti ME, Grandolfo M, Mele A. Vaccination campaign against hepatitis B for 12-year-old subjects in Italy. Vaccine. 1997;15:583-5.
2. Stroffolini T, Mele A, Tosti ME, Gallo G, Balocchini E, Ragni P, Santonastasi F, Marzolini A, Ciccozzi M, Moiraghi A. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol. 2000;33:980-5.
3. Mele A, Tosti ME, Mariano A, Pizzuti R, Ferro A, Borrini B, Zotti C, Lopalco P, Curtale F, Balocchini E, Spada E; National Surveillance System for Acute Viral Hepatitis (SEIEVA) Collaborating Group. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis. 2008;46:868-75.
4. Zanetti AR, Mariano A, Romanò L, D'Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, Parlato A, Zamparo E, Zotti C, Stroffolini T, Mele A; Study Group. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet. 2005;366:1379-84.
5. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, Caroleo B, Costa C, Griffo G, Loiacono L, Pisani V, Focà A, Piazza M. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology. 1997;26:1006-11.
6. Stroffolini T, Guadagnino V, Chionne P, Procopio B, Mazzuca EG, Quintieri F, Scerbo P, Giancotti A, Nisticò S, Focà A, Tosti ME, Rapicetta M. A population based survey of hepatitis B virus infection in a southern Italian town. Ital J Gastroenterol Hepatol. 1997;29:415-8.
7. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med. 2001;135:796-800.
8. Whittle H, Jaffar S, Wansbrough M, Mendy M, Dumpis U, Collinson A, Hall A. Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. BMJ. 2002;325:569.
9. Liao SS, Li RC, Li H, Yang JY, Zeng XJ, Gong J, Wang SS, Li YP, Zhang KL. Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children. Vaccine. 1999;17:2661-6.
10. McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, Khristova M, Zanis C, Peters H, Margolis HS. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med. 2005;142: 333-41.
11. Huang LM, Chiang BL, Lee CY, Lee PI, Chi WK, Chang MH. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen. Hepatology. 1999;29:954-9.
12. Agladioglu SY, Beyazova U, Camurdan AD, Sahin F, Atak A. Immunogenicity of two different hepatitis B vaccine schedules. Infection. 2011;39:489-90.
13. Das RR, Mathew JL, Ratho RK. Alternate schedules of hepatitis B vaccination: which one is better? Infection. 2011;39:175-6.
14. Bracciale L, Fabbiani M, Sansoni A, Luzzi L, Bernini L, Zanelli G. Impact of hepatitis B vaccination in children born to HBsAgpositive mothers: a 20-year retrospective study. Infection. 2009;37:340-3.